Works matching IS 00302414 AND DT 2023 AND VI 101 AND IP 9

Results: 8

Front & Back Matter.
Published in:
Oncology, 2023, v. 101, n. 9, p. 1, doi. 10.1159/000533949
Publication type:
Article
Effectiveness of Palonosetron, 1-Day Dexamethasone, and Aprepitant in Patients Undergoing Carboplatin-Based Chemotherapy.
Published in:
Oncology, 2023, v. 101, n. 9, p. 584, doi. 10.1159/000531318
By:
- Hayashi, Toshinobu;
- Shimokawa, Mototsugu;
- Matsuo, Koichi;
- Uchiyama, Masanobu;
- Kawada, Kei;
- Nakano, Takafumi;
- Egawa, Takashi
Publication type:
Article
Response Prediction Model of Atezolizumab plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Retrospective Study.
Published in:
Oncology, 2023, v. 101, n. 9, p. 565, doi. 10.1159/000531317
By:
- Ueno, Masaki;
- Kosaka, Hisashi;
- Iida, Hiroya;
- Ida, Yoshiyuki;
- Aoi, Kazunori;
- Mori, Haruki;
- Miyamoto, Atsushi;
- Nishida, Yuko;
- Hayami, Shinya;
- Kawai, Manabu;
- Kaibori, Masaki
Publication type:
Article
Overexpression of SOX2 Gene by Histone Modifications: SOX2 Enhances Human Prostate and Breast Cancer Progression by Prevention of Apoptosis and Enhancing Cell Proliferation.
Published in:
Oncology, 2023, v. 101, n. 9, p. 591, doi. 10.1159/000531195
By:
- Kar, Swayamsiddha;
- Niharika;
- Roy, Ankan;
- Patra, Samir Kumar
Publication type:
Article
Usefulness of aMAP Risk Score for Predicting Recurrence after Curative Treatment for Hepatocellular Carcinoma within Milan Criteria.
Published in:
Oncology, 2023, v. 101, n. 9, p. 575, doi. 10.1159/000530987
By:
- Ohama, Hideko;
- Hiraoka, Atsushi;
- Tada, Fujimasa;
- Kato, Kanako;
- Fukunishi, Yoshiko;
- Yanagihara, Emi;
- Kato, Masaya;
- Saneto, Hironobu;
- Izumoto, Hirofumi;
- Ueki, Hidetaro;
- Yoshino, Takeaki;
- Kitahata, Shogo;
- Kawamura, Tomoe;
- Kuroda, Taira;
- Suga, Yoshifumi;
- Miyata, Hideki;
- Hirooka, Masashi;
- Abe, Masanori;
- Matsuura, Bunzo;
- Ninomiya, Tomoyuki
Publication type:
Article
Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings.
Published in:
Oncology, 2023, v. 101, n. 9, p. 542, doi. 10.1159/000530028
By:
- Ohama, Hideko;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Efficacy of Lipophilic Statins on Outcomes of Patients Treated with Immune Checkpoint Inhibitors.
Published in:
Oncology, 2023, v. 101, n. 9, p. 537, doi. 10.1159/000529644
By:
- Chiang, Cho-Han;
- Chen, Yuan-Jen;
- See, Xin Ya;
- Chang, Yu-Cheng;
- Wang, Shih-Syuan;
- Peng, Chun-Yu;
- Horng, Chuan-Sheng;
- Hsia, Yuan Ping;
- Chiang, Cho-Hung;
- Peng, Cheng-Ming;
- Chiang, Cho-Hsien
Publication type:
Article
Neoadjuvant Management of Adenocarcinoma of the Esophagus and Esophagogastric Junction: Review of Randomized Evidence and Definition of Optimum Treatment Algorithm.
Published in:
Oncology, 2023, v. 101, n. 9, p. 553, doi. 10.1159/000527716
By:
- Hingorani, Mohan;
- Goody, Rebecca;
- Bozas, Georgios;
- Zahid, Khwaja;
- Mitton, David James;
- Jain, Prashant;
- Wong, Vincent;
- Roy, Rajarshi
Publication type:
Article